ALVEOLAR ECHINOCOCCOSIS

Clinical trials for ALVEOLAR ECHINOCOCCOSIS explained in plain language.

Never miss a new study

Get alerted when new ALVEOLAR ECHINOCOCCOSIS trials appear

Sign up with your email to follow new studies for ALVEOLAR ECHINOCOCCOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Can a Parasite-Fighting drug halt a nearly 100% fatal disease?

Disease control Completed

This study tested the drug albendazole in 194 people with early-stage alveolar echinococcosis, a parasitic liver disease that is almost always fatal within 10-15 years if untreated. The goal was to see if the drug could stop the parasite lesions from growing. Albendazole is known…

Matched conditions: ALVEOLAR ECHINOCOCCOSIS

Phase: PHASE2 • Sponsor: Ministry of Health, Kyrgyzstan • Aim: Disease control

Last updated May 11, 2026 20:50 UTC

ALVEOLAR ECHINOCOCCOSIS

Get alerted when new ALVEOLAR ECHINOCOCCOSIS trials appear

Can a Parasite-Fighting drug halt a nearly 100% fatal disease?